ANDREW CIVITELLO to Risk Assessment
This is a "connection" page, showing publications ANDREW CIVITELLO has written about Risk Assessment.
Connection Strength
0.080
-
Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: A single-center experience. J Thorac Cardiovasc Surg. 2019 10; 158(4):1083-1089.e1.
Score: 0.021
-
Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support. Ann Thorac Surg. 2019 04; 107(4):1132-1138.
Score: 0.021
-
Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2018 08; 106(2):513-519.
Score: 0.020
-
A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience. JACC Cardiovasc Interv. 2009 Feb; 2(2):91-6.
Score: 0.010
-
Clinical experience with the TandemHeart percutaneous ventricular assist device. Tex Heart Inst J. 2006; 33(2):111-5.
Score: 0.008